New technology enables the insertion of a large segment of DNA into a genome, potentially expanding gene therapy treatment ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
Retrons adapted from E. coli enable genome editing in 15 diverse bacterial species, expanding recombineering tools across major microbial phyla.
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox– Additional presentations ...
Profluent and Lilly teamed up on AI‑designed enzymes in a deal worth up to $2.25B. Big tech, bigger gene edits.
Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise ...
This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating genome editing.
The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current ...
The ability to precisely edit the genomes of bacteria has long been a goal of microbiologists. Such technology would enable ...
Waking up this morning to news of the much-deserved Nobel Prize win for Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing" confirms the importance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results